Filtration leukocytapheresis therapy ameliorates lipopolysaccharide-induced systemic inflammation in a rat model

Journal of Surgical Research

Volumn 171, Issue 2, 2011, Pages 777-782

  Hagiwara, Satoshi ^a   Iwasaka, Hideo ^a   Hasegawa, Akira ^a   Hidaka, Seigo ^a   Uno, Aya ^a   Ueo, Kaori ^a   Uchida, Tomohisa ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

interleukin 6; leukocytapheresis; liver injury; lung injury; systemic inflammation; tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SEVOFLURANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FILTRATION; CONTROLLED STUDY; CYTAPHERESIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTOLOGY; INFLAMMATION; LEUKOCYTAPHERESIS THERAPY; LIVER; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; HMGB1 PROTEIN; INFLAMMATION; INTERLEUKIN-6; LEUKAPHERESIS; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81155146148     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.06.021     Document Type: Article

References (20)

1. J.C. Marshall Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome Crit Care Med 29 2001 S99
2. J.A. Russell, J. Singer, and G.R. Bernard Changing pattern of organ dysfunction in early human sepsis is related to mortality Crit Care Med 28 2000 3405
3. G. Bellingan Inflammatory cell activation in sepsis Br Med Bull 55 1999 12
4. S. Akira, and K. Takeda Toll-like receptor signaling Nat Rev Immunol 4 2004 499
5. F. Balkwill Cytokines - soluble factors in immune responses Curr Opin Immunol 1 1988 241
6. M. Bustin Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins Mol Cell Biol 19 1999 5237
7. A. Rouhiainen, S. Tumova, and L. Valmu Pivotal advance: Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin) J Leukoc Biol 81 2007 49
8. D. Yang, Q. Chen, and H. Yang High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin J Leukoc Biol 81 2007 59
9. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248
10. H. Ueno, T. Matsuda, and S. Hashimoto Contributions of high mobility group box protein in experimental and clinical acute lung injury Am J Respir Crit Care Med 170 2004 1310
11. R.M. Levy, K.P. Mollen, and J.M. Prince Systemic inflammation and remote organ injury following trauma require HMGB1 Am J Physiol Regul Integr Comp Physiol 293 2007 R1538
12. J.M. Cavaillon, and D. Annane Compartmentalization of the inflammatory response in sepsis and SIRS J Endotoxin Res 12 2006 151
13. K. Murakami, R. McGuire, and R.A. Cox Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep Shock 18 2002 236
14. B.H. Heijnen, I.H. Straatsburg, and D.J. Gouma Decrease in core liver temperature with 10 degrees C by in situ hypothermic perfusion under total hepatic vascular exclusion reduces liver ischemia and reperfusion injury during partial hepatectomy in pigs Surgery 134 2003 806
15. J.A. Russell Management of sepsis N Engl J Med 355 2006 1699
16. W.J. Kox, T. Volk, and S.N. Kox Immunomodulatory therapies in sepsis Intensive Care Med 26 2000 S124
17. S. Hagiwara, H. Iwasaka, and S. Matumoto Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models Crit Care Med 37 2009 626
18. S. Hagiwara, H. Iwasaka, and S. Hidaka Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats Crit Care 12 2008 R43
19. R.C. Bone Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation Crit Care Med 24 1996 163
20. H.R. Michie Detection of circulating tumor necrosis factor after endotoxin administration N Engl J Med 318 1988 1481